Raja Kumaraguru
Stock Analyst at Roth MKM
(n/a)
# 4,407
Out of 4,761 analysts
5
Total ratings
n/a
Success rate
-43.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raja Kumaraguru
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAIN Rain Enhancement Technologies Holdco | Downgrades: Neutral | $1.2 | $2.64 | -54.55% | 1 | May 30, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $480 | $1.95 | +24,515.38% | 1 | Mar 12, 2021 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $15,000 | $3.23 | +464,296.28% | 1 | Feb 2, 2021 | |
| FBRX Forte Biosciences | Initiates: Buy | $2,250 | $10.98 | +20,391.80% | 1 | Aug 28, 2020 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $210 | $40.25 | +421.74% | 1 | Feb 19, 2020 |
Rain Enhancement Technologies Holdco
May 30, 2023
Downgrades: Neutral
Price Target: $1.2
Current: $2.64
Upside: -54.55%
NLS Pharmaceutics AG
Mar 12, 2021
Initiates: Buy
Price Target: $480
Current: $1.95
Upside: +24,515.38%
CNS Pharmaceuticals
Feb 2, 2021
Initiates: Buy
Price Target: $15,000
Current: $3.23
Upside: +464,296.28%
Forte Biosciences
Aug 28, 2020
Initiates: Buy
Price Target: $2,250
Current: $10.98
Upside: +20,391.80%
Monopar Therapeutics
Feb 19, 2020
Initiates: Buy
Price Target: $210
Current: $40.25
Upside: +421.74%